Naldemedine

Overview

Naldemedine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2105755).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Naldemedine expires 13 May 2033. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,7,9-trihydroxy-N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-6-carboxamide

Canonical SMILES

CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C([C@H]4[C@@]56CCN([C@@H]([C@@]5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O

InChIKey

AXQACEQYCPKDMV-RZAWKFBISA-N